208 related articles for article (PubMed ID: 19568412)
1. Type I insulin-like growth factor receptor induces pulmonary tumorigenesis.
Linnerth NM; Siwicky MD; Campbell CI; Watson KL; Petrik JJ; Whitsett JA; Moorehead RA
Neoplasia; 2009 Jul; 11(7):672-82. PubMed ID: 19568412
[TBL] [Abstract][Full Text] [Related]
2. The function of IGF-IR in NNK-mediated lung tumorigenesis.
Siwicky MD; Petrik JJ; Moorehead RA
Lung Cancer; 2011 Jan; 71(1):11-8. PubMed ID: 20399527
[TBL] [Abstract][Full Text] [Related]
3. IGF-IR mediated mammary tumorigenesis is enhanced during pubertal development.
Jones RA; Watson KL; Campbell CI; Moorehead RA
PLoS One; 2014; 9(9):e108781. PubMed ID: 25259518
[TBL] [Abstract][Full Text] [Related]
4. Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice.
Watson KL; Moorehead RA
BMC Cancer; 2013 Aug; 13():375. PubMed ID: 23919516
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
Jones RA; Campbell CI; Petrik JJ; Moorehead RA
Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
[TBL] [Abstract][Full Text] [Related]
6. High levels of dietary soy decrease mammary tumor latency and increase incidence in MTB-IGFIR transgenic mice.
Watson KL; Stalker L; Jones RA; Moorehead RA
BMC Cancer; 2015 Feb; 15():37. PubMed ID: 25655427
[TBL] [Abstract][Full Text] [Related]
7. Mammary tumors that become independent of the type I insulin-like growth factor receptor express elevated levels of platelet-derived growth factor receptors.
Campbell CI; Moorehead RA
BMC Cancer; 2011 Nov; 11():480. PubMed ID: 22070644
[TBL] [Abstract][Full Text] [Related]
8. Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature.
Franks SE; Campbell CI; Barnett EF; Siwicky MD; Livingstone J; Cory S; Moorehead RA
Oncogene; 2012 Jul; 31(27):3298-309. PubMed ID: 22020329
[TBL] [Abstract][Full Text] [Related]
9. The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis.
Jones RA; Moorehead RA
J Mammary Gland Biol Neoplasia; 2008 Dec; 13(4):407-13. PubMed ID: 19002570
[TBL] [Abstract][Full Text] [Related]
10. Preneoplastic changes persist after IGF-IR downregulation and tumor regression.
Jones RA; Petrik JJ; Moorehead RA
Oncogene; 2010 Aug; 29(34):4779-86. PubMed ID: 20543862
[TBL] [Abstract][Full Text] [Related]
11. Elevated epithelial insulin-like growth factor expression is a risk factor for lung cancer development.
Kim WY; Jin Q; Oh SH; Kim ES; Yang YJ; Lee DH; Feng L; Behrens C; Prudkin L; Miller YE; Lee JJ; Lippman SM; Hong WK; Wistuba II; Lee HY
Cancer Res; 2009 Sep; 69(18):7439-48. PubMed ID: 19738076
[TBL] [Abstract][Full Text] [Related]
12. Reversibility and recurrence of IGF-IR-induced mammary tumors.
Jones RA; Campbell CI; Wood GA; Petrik JJ; Moorehead RA
Oncogene; 2009 May; 28(21):2152-62. PubMed ID: 19377512
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of Clara cell secretory protein expression in a transgenic model of mouse lung carcinogenesis.
Hicks SM; Vassallo JD; Dieter MZ; Lewis CL; Whiteley LO; Fix AS; Lehman-McKeeman LD
Toxicology; 2003 May; 187(2-3):217-28. PubMed ID: 12699910
[TBL] [Abstract][Full Text] [Related]
14. Transgenic overexpression of IGF-IR disrupts mammary ductal morphogenesis and induces tumor formation.
Jones RA; Campbell CI; Gunther EJ; Chodosh LA; Petrik JJ; Khokha R; Moorehead RA
Oncogene; 2007 Mar; 26(11):1636-44. PubMed ID: 16953219
[TBL] [Abstract][Full Text] [Related]
15. Differential impacts of insulin-like growth factor-binding protein-3 (IGFBP-3) in epithelial IGF-induced lung cancer development.
Kim WY; Kim MJ; Moon H; Yuan P; Kim JS; Woo JK; Zhang G; Suh YA; Feng L; Behrens C; Van Pelt CS; Kang H; Lee JJ; Hong WK; Wistuba II; Lee HY
Endocrinology; 2011 Jun; 152(6):2164-73. PubMed ID: 21447628
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
[TBL] [Abstract][Full Text] [Related]
17. Transgenic overexpression of IGF-II induces spontaneous lung tumors: a model for human lung adenocarcinoma.
Moorehead RA; Sanchez OH; Baldwin RM; Khokha R
Oncogene; 2003 Feb; 22(6):853-7. PubMed ID: 12584565
[TBL] [Abstract][Full Text] [Related]
18. FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo.
Clark JC; Tichelaar JW; Wert SE; Itoh N; Perl AK; Stahlman MT; Whitsett JA
Am J Physiol Lung Cell Mol Physiol; 2001 Apr; 280(4):L705-15. PubMed ID: 11238011
[TBL] [Abstract][Full Text] [Related]
19. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
20. Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.
Franks SE; Briah R; Jones RA; Moorehead RA
Oncotarget; 2016 Jan; 7(3):3297-316. PubMed ID: 26654940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
